|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006118,
umls-concept:C0015576,
umls-concept:C0017262,
umls-concept:C0086418,
umls-concept:C0215991,
umls-concept:C0680022,
umls-concept:C0812246,
umls-concept:C1171362,
umls-concept:C1456820,
umls-concept:C1515670,
umls-concept:C1824671
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2002-3-28
|
|
pubmed:abstractText |
CD70 (CD27 ligand) has been implicated in proapoptotic signals mediated by its receptor CD27 in lymphocytes as well as in proliferative effects induced by reverse signaling in CD70-positive hematopoetic tumor cells. We were able to show that CD70 is expressed at the mRNA and protein level in human meningioma cells, glioma cells from solid human gliomas as well as glioma cell lines and 1 ependynoma. The intensity of CD70 expression varies considerably between different samples from 1 tumor type. In the U343 glioma cell line, CD70 was preferentially localized in the cell processes. Thus, our studies identify CD70 as a new marker molecule in brain tumors that are of nonhematopoetic origin.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD70,
http://linkedlifedata.com/resource/pubmed/chemical/CD70 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0020-7136
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2002 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
20
|
|
pubmed:volume |
98
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
352-6
|
|
pubmed:dateRevised |
2008-5-14
|
|
pubmed:meshHeading |
pubmed-meshheading:11920585-Antigens, CD,
pubmed-meshheading:11920585-Antigens, CD70,
pubmed-meshheading:11920585-Blotting, Northern,
pubmed-meshheading:11920585-Blotting, Western,
pubmed-meshheading:11920585-Brain Neoplasms,
pubmed-meshheading:11920585-Cells, Cultured,
pubmed-meshheading:11920585-DNA Primers,
pubmed-meshheading:11920585-Ependymoma,
pubmed-meshheading:11920585-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:11920585-Glioma,
pubmed-meshheading:11920585-Humans,
pubmed-meshheading:11920585-Immunoenzyme Techniques,
pubmed-meshheading:11920585-Ligands,
pubmed-meshheading:11920585-Membrane Proteins,
pubmed-meshheading:11920585-Meningeal Neoplasms,
pubmed-meshheading:11920585-Meningioma,
pubmed-meshheading:11920585-RNA, Messenger,
pubmed-meshheading:11920585-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:11920585-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
CD70/CD27 ligand, a member of the TNF family, is expressed in human brain tumors.
|
|
pubmed:affiliation |
Department of Anatomy, University of Kiel, Kiel, Germany. held-feindt@anat.uni-kiel.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
